Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients.
Brivio, F
Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients. [electronic resource] - Journal of biological regulators and homeostatic agents - 200-3 p. digital
Publication Type: Clinical Trial; Evaluation Study; Journal Article
0393-974X
Aged
CD11 Antigens--blood
Colorectal Neoplasms--surgery
Dendritic Cells--drug effects
Female
Humans
Interleukin-2--therapeutic use
Lymphopenia--prevention & control
Male
Middle Aged
Postoperative Complications--prevention & control
Preoperative Care
Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients. [electronic resource] - Journal of biological regulators and homeostatic agents - 200-3 p. digital
Publication Type: Clinical Trial; Evaluation Study; Journal Article
0393-974X
Aged
CD11 Antigens--blood
Colorectal Neoplasms--surgery
Dendritic Cells--drug effects
Female
Humans
Interleukin-2--therapeutic use
Lymphopenia--prevention & control
Male
Middle Aged
Postoperative Complications--prevention & control
Preoperative Care